Smruthi Organics logo

Smruthi Organics

SMRUTHIORGANICSLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹185 Cr
Volatility
Moderate
P/E Ratio
25
EBITDA
₹13.20 Cr
Return on Equity
4.66%
Debt to Equity
0.11
Book Value
₹64.22
EPS
₹0.33
52W High
₹175.3
52W Low
₹95

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company has been maintaining a healthy dividend payout of 48.7%
  • Debtor days have improved from 93.5 to 69.1 days.

Weaknesses

2
  • The company has delivered a poor sales growth of -4.22% over past five years.
  • Company has a low return on equity of 5.14% over last 3 years.

Growth Rate

Revenue Growth
-19.03% lower than 3Y
Net Income Growth
-5.56% lower than 3Y
Cash Flow Change
123% lower than 3Y
ROE
-6.24% lower than 3Y
ROCE
-1.67% lower than 3Y
EBITDA Margin (Avg.)
32.48% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
34.91
29.59
23.48
39.66
27.27
29.39
31.25
38.09
18.85
31.6
22.29
29.05
29.3
Expenses
30.29
25.16
24.66
35.58
26.82
26.5
27.08
33.41
18.56
26.59
18.29
25.15
23.49
Operating Profit
4.62
4.43
-1.18
4.08
0.45
2.89
4.17
4.68
0.29
5.01
4
3.9
5.81
OPM %
13.23%
14.97%
-5.03%
10.29%
1.65%
9.83%
13.34%
12.29%
1.54%
15.85%
17.95%
13.43%
19.83%
Other Income
0.01
0
0
0.06
0
0.01
0
0.08
0.04
0.01
-0.44
-0.07
-0.04
Interest
0.33
0.39
0.32
0.37
0.41
0.44
0.51
0.52
0.46
0.66
0.25
0.31
0.31
Depreciation
1.24
1.38
1.45
1.59
1.29
1.33
1.37
1.5
1.41
1.51
1.67
1.75
1.6
PBT
3.06
2.66
-2.95
2.18
-1.25
1.13
2.29
2.74
-1.54
2.85
1.64
1.77
3.86
Tax %
25.49%
22.56%
-22.03%
30.73%
-26.4%
31.86%
35.37%
18.61%
-28.57%
27.72%
14.63%
39.55%
25.65%
Net Profit
2.29
2.07
-2.29
1.52
-0.92
0.78
1.48
2.23
-1.1
2.06
1.4
1.07
2.88
EPS in Rs
2
1.81
-2
1.33
-0.8
0.68
1.29
1.95
-0.96
1.8
1.22
0.93
2.52
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
77
74
79
97
137
131
126
133
141
128
126
102
112
Expenses
72
63
69
94
121
116
98
115
131
116
114
89
94
Operating Profit
5
11
10
3
17
15
29
18
10
12
12
13
19
OPM %
6%
14%
13%
3.4%
12%
12%
23%
14%
7%
9%
10%
13%
17%
Other Income
0
0
1
0
1
4
1
1
0
0
0
0
-1
Interest
6
5
4
4
4
3
1
1
1
1
2
2
2
Depreciation
5
4
4
4
4
4
4
4
5
6
6
6
7
PBT
-6
2
3
-5
10
12
24
14
4
5
5
5
10
Tax %
-33%
55%
39%
-31%
30%
30%
29%
25%
8%
28%
27%
27%
—
Net Profit
-4
1
2
-3
7
8
17
10
4
4
4
3
7
EPS in Rs
-3.34
0.63
1.39
-2.82
6.02
7.41
14.95
9.07
3.61
3.14
3.11
3
6.47
Div. Payout %
0%
0%
0%
0%
11%
14%
20%
33%
55%
48%
48%
50%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4
4
4
4
4
4
11
11
11
11
11
11
Reserves
26
27
28
25
33
39
49
56
57
58
60
62
Borrowings
45
37
33
31
28
16
10
3
6
12
17
8
Other Liabilities
34
35
20
25
37
30
21
18
32
37
23
22
Total Liabilities
109
103
85
85
101
88
92
88
106
118
112
104
Fixed Assets
35
32
30
30
30
32
31
33
37
40
45
47
CWIP
1
1
1
1
2
0
1
1
2
1
3
3
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
72
69
54
54
69
56
60
53
66
77
64
54
Total Assets
109
103
85
85
101
88
92
88
106
118
112
104
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
9
14
9
5
12
21
23
2
12
4
10
22
Investing
-1
0
0
-3
-4
-5
-3
7
-10
-7
-11
-9
Financing
-8
-14
-9
-2
-5
-17
-7
-12
-2
3
1
-12
Net Cash Flow
-1
0
0
0
2
-1
13
-3
0
0
0
1
Free Cash Flow
7
13
8
1
7
17
19
-4
3
-4
-2
14
CFO/OP
184
128
93
159
71
160
101
33
136
46
100
182
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
103
95
97
95
97
68
62
78
96
117
94
69
Inventory Days
123
166
145
126
92
75
100
91
96
150
151
228
Days Payable
106
128
123
130
120
97
81
50
98
144
85
111
Cash Conversion Cycle
120
133
119
92
68
46
80
118
93
123
160
186
Working Capital Days
2
8
1
7
78
32
52
99
73
94
92
85
ROCE %
0%
9%
10%
-1%
21%
25%
39%
21%
7%
8%
8%
8%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Smruthi Organics insights

67 extracted metrics + investor summaries across FY09–FY26.

Log in — free

Shareholding Pattern

Promot.64.73%Others6.62%Public28.65%As ofJun 2026

Documents

Frequently Asked Questions about Smruthi Organics

What does Smruthi Organics Ltd do?
Incorporated in 1989, Smruthi Organics Ltd is a manufacturer of Active Pharmaceutical Ingredients[1]
Where is Smruthi Organics Ltd (540686) listed?
Smruthi Organics Ltd trades as SMRUTHIORGANICSLTD on the NSE and under code SMRUTHIORG on the BSE.
Which sector does Smruthi Organics Ltd belong to?
Smruthi Organics Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Smruthi Organics Ltd?
Smruthi Organics Ltd has a market capitalisation of ₹185.47 Cr, which places it in the Small Cap band.
What is the PE ratio of Smruthi Organics Ltd?
Smruthi Organics Ltd trades at a PE ratio of 25.00, on earnings per share of ₹0.33, against a book value of ₹64.22 per share.
What is the 52-week high and low of Smruthi Organics Ltd?
Over the last 52 weeks Smruthi Organics Ltd has traded between ₹95 and ₹175.3.
Does Smruthi Organics Ltd pay dividends?
Smruthi Organics Ltd has a dividend yield of 0.93%.
What is the Return on Equity (ROE) of Smruthi Organics Ltd?
Smruthi Organics Ltd reported a return on equity of 4.66%. Its debt-to-equity ratio is 0.11.

Company Information

Incorporated in 1989, Smruthi Organics Ltd is a manufacturer of Active Pharmaceutical Ingredients[1]

Website smruthiorganics.com
Listed 2017-08-29
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/540686.md for Smruthi Organics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List